Original Article

You have full text access to this OnlineOpen article

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia

A metaanalysis

  1. Masamitsu Yanada MD1,†,*,
  2. Keitaro Matsuo MD2,
  3. Takeshi Suzuki MD2,
  4. Tomoki Naoe MD1

Article first published online: 15 MAY 2006

DOI: 10.1002/cncr.21932

Issue

Cancer

Cancer

Volume 106, Issue 12, pages 2657–2663, 15 June 2006

Additional Information

How to Cite

Yanada, M., Matsuo, K., Suzuki, T. and Naoe, T. (2006), Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia. Cancer, 106: 2657–2663. doi: 10.1002/cncr.21932

Author Information

  1. 1

    Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  2. 2

    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

  1. †

    Fax: (011) 81 527442801

*Department of Hematology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan

Publication History

  1. Issue published online: 1 JUN 2006
  2. Article first published online: 15 MAY 2006
  3. Manuscript Accepted: 2 FEB 2006
  4. Manuscript Revised: 19 JAN 2006
  5. Manuscript Received: 4 NOV 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (125K)

REFERENCES

  • 1
    Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988; 71: 123–131.
  • 2
    Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood. 1995; 85: 2025–2037.
  • 3
    Durrant IJ, Prentice HG, Richards SM. Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults. Br J Haematol. 1997; 99: 84–92.
    Direct Link:
  • 4
    Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000; 18: 547–561.
  • 5
    Annino L, Vegna ML, Camera A, et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood. 2002; 99: 863–871.
  • 6
    Wheatley K. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?—a statistician's view. Br J Haematol. 2002; 118: 351–356.
    Direct Link:
  • 7
    Yanada M, Matsuo K, Emi N, Naoe T. Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis. Cancer. 2005; 103: 1652–1658.
    Direct Link:
  • 8
    Sebban C, Lepage E, Vernant JP, et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. J Clin Oncol. 1994; 12: 2580–2587.
  • 9
    Attal M, Blaise D, Marit G, et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood. 1995; 86: 1619–1628.
  • 10
    Takeuchi J, Kyo T, Naito K, et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia. 2002; 16: 1259–1266.
  • 11
    Dombret H, Gabert J, Boiron JM, et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia—results of the prospective multicenter LALA-94 trial. Blood. 2002; 100: 2357–2366.
  • 12
    Thomas X, Boiron JM, Huguet F, et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004; 22: 4075–4086.
  • 13
    Hunault M, Harousseau JL, Delain M, et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood. 2004; 104: 3028–3037.
  • 14
    Labar B, Suciu S, Zittoun R, et al. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients < or = 50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica. 2004; 89: 809–817.
  • 15
    Ribera JM, Oriol A, Bethencourt C, et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica. 2005; 90: 1346–1356.
  • 16
    Fiere D, Lepage E, Sebban C, et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. J Clin Oncol. 1993; 11: 1990–2001.
  • 17
    De Witte T, Awwad B, Boezeman J, et al. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant. 1994; 14: 767–774.
  • 18
    Dekker AW, van't Veer MB, Sizoo W, et al. Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group. J Clin Oncol. 1997; 15: 476–482.
  • 19
    Ifrah N, Witz F, Jouet JP, et al. Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group. Cancer. 1999; 86: 1496–1505.
    Direct Link:
  • 20
    Gupta V, Yi QL, Brandwein J, et al. The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor versus no donor comparison. Bone Marrow Transplant. 2004; 33: 397–404.
  • 21
    Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform metaanalyses of the published literature for survival endpoints. Stat Med. 1998; 17: 2815–2834.
    Direct Link:
  • 22
    Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Metaanalysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2004; 22: 3852–3859.
  • 23
    DerSimonian R, Laird N. Metaanalysis in clinical trials. Control Clin Trials. 1986; 7: 177–188.
  • 24
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088–1101.
  • 25
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997; 315: 629–634.
  • 26
    Sharp S. Metaanalysis regression. Stata Tech Bull. 1998; 42: 16–24.
  • 27
    Rowe J, Richards S, Burnett A. Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): results from the International ALL Trial (MRC UKALL XII/ECOG E2993) [abstract]. Blood. 2001; 98(Suppl 1): 2009.
  • 28
    Gorin NC. Autologous stem cell transplantation in acute lymphocytic leukemia. Stem Cells. 2002; 20: 3–10.
    Direct Link:
  • 29
    Nathan PC, Sung L, Crump M, Beyene J. Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a metaanalysis. J Natl Cancer Inst. 2004; 96: 38–45.
View Full Article (HTML) Get PDF (125K)